Table 3. Target Vessel, Stent Length and Stent Diameter of the included studies.
No. | Published | Target Vessel | Stent Length | Stent Diameter | |||||||||||||
drugs | RCA | LCX | LAD | (mm+SD) | (mm+SD) | ||||||||||||
DP | BMS | DP | BMS | DP | BMS | DP | BMS | DP | BMS | DP | BMS | ||||||
1 | Lemos 2012 | paclitaxel | bare | 33.3 | 15.8 | 44.1 | 57.9 | 22.5 | 26.3 | 22.5 | 5.5 | 22.5 | 5 | 3.1 | 0.4 | 3.1 | 0.4 |
Sirolimus | bare | 25.5 | 15.8 | 56.6 | 57.9 | 17.9 | 26.3 | 21.8 | 4.8 | 22.5 | 5 | 3.1 | 0.3 | 3.1 | 0.4 | ||
2 | Silber 2011 | paclitaxel | bare | 36 | 31.3 | 23.8 | 27 | 39 | 40.5 | 16.98 | 6.74 | 17.01 | 8.29 | NA | NA | NA | NA |
3 | Grube 2005 | biolimus | bare | 34.1 | 27.5 | 37.8 | 30 | 28 | 42.5 | 19.03 | 8.76 | 16.23 | 5.53 | NA | NA | NA | NA |
4 | Räber 2012 | biolimus | bare | 45.9 | 44.6 | 14.3 | 15.5 | 39.3 | 39.6 | 25.2 | 12.7 | 24.1 | 12.3 | 3.2 | 0.4 | 3.2 | 1.1 |
5 | Rodriguez 2011 | Paclitaxel | bare | 17.6 | 25.1 | 18.5 | 23.8 | 62.8 | 48.5 | 21.7 | 5.6 | 20 | 4.8 | 2.96 | 0.4 | 2.93 | 0.6 |
6 | Reifart 2010 | sirolimus | bare | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
7 | Grube 2004 | Everolimus | bare | 41 | 27 | 18 | 13 | 41 | 60 | NA | NA | NA | NA | NA | NA | NA | NA |